- Home
- AXSM vs MMSI Comparison
AXSM vs MMSI Comparison
Compare AXSM & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXSM | MMSI |
|---|---|---|
| Founded | 2012 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 4.8B |
| IPO Year | 2015 | 1990 |
Fundamental Metrics
Financial Performance| Metric | AXSM | MMSI |
|---|---|---|
| Price | $148.69 | $87.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 20 | 8 |
| Target Price | ★ $176.00 | $105.38 |
| AVG Volume (30 Days) | 495.6K | ★ 620.0K |
| Earning Date | 11-03-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.95 |
| Revenue | $561,263,000.00 | ★ $1,477,128,000.00 |
| Revenue This Year | $66.20 | $13.53 |
| Revenue Next Year | $57.56 | $6.30 |
| P/E Ratio | ★ N/A | $44.51 |
| Revenue Growth | ★ 65.83 | 11.41 |
| 52 Week Low | $75.56 | $78.12 |
| 52 Week High | $152.94 | $111.45 |
Technical Indicators
Market Signals| Indicator | AXSM | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 56.98 | 58.26 |
| Support Level | $145.07 | $85.79 |
| Resistance Level | $149.13 | $87.86 |
| Average True Range (ATR) | 4.15 | 1.71 |
| MACD | -0.77 | 0.22 |
| Stochastic Oscillator | 61.43 | 77.61 |
Price Performance
Historical ComparisonAbout AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About MMSI Merit Medical Systems Inc.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.